Comments
The 14th edition of Telangana’s flagship biotech and pharma summit, BioAisa, will be held during February 6-8, 2017.
About 1,500 delegates and representatives of 800 from across 50 countries were expected to participate in the conference.
The prominent speakers include Paul Stoffels, Worldwide Chairman of Pharmaceuticals and Chief Scientific Officer, Johnson & Johnson, Vasant Narasimhan, Global Head of Drug Development and Chief Medical Officer for Novartis and Patrick Vallance, President Worldwide Pharmaceuticals, R&D – GSK, among others.
“In its journey of 14 years, BioAsia has emerged as the largest life science event in India and one of the pre-eminent meetings in Asia. BioAsia 2017 is expected to be bigger,’’ Shakthi Nagappan, Chief Executive Officer, BioAsia said in a release issued here on Thursday.
BioAsia 2016 witnessed participation of around 1300 registered delegates from 50 countries. It also conducted around 1200 trade, partnership meetings.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.